mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.034 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |